Home › Funds › GMT CAPITAL CORP › CLOV

GMT CAPITAL CORP position in CLOV

CLOVER HEALTH INVESTMENTS CO · Health Care

GMT CAPITAL CORP reported holding 1,305,200 shares of CLOV (CLOVER HEALTH INVESTMENTS CO) in its Q2 2026 13F filing — a position valued at US$6.8M, representing 0.36% of its reported portfolio and ranking #25 among its reported holdings. GMT CAPITAL CORP has disclosed CLOV holdings in 9 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.31M sh
Reported value held$6.84M
Portfolio Weight0.36%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How GMT CAPITAL CORP's CLOV position evolved

GMT CAPITAL CORP first disclosed a stake in CLOV in Q3 2023 at 1,305,200 shares (US$1.4M). The position peaked in Q2 2026 at 1,305,200 shares, worth US$6.8M. Across 9 filings, GMT CAPITAL CORP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,305,200 shares valued at US$6.8M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.31M $1.41M New
Q1 2024 1.31M $1.04M New
Q2 2024 1.31M $1.61M Hold
Q3 2024 1.31M $3.68M Hold
Q1 2025 1.31M $4.69M New
Q2 2025 1.31M $3.64M Hold
Q3 2025 1.31M $3.99M Hold
Q1 2026 1.31M $2.30M New
Q2 2026 1.31M $6.84M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CLOV and 13F data

CLOV (CLOVER HEALTH INVESTMENTS CO) is a Health Care company. 51 other funds we track also report a position in CLOV. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CLOV

No other tracked fund reports a position in CLOV.

All CLOV fund holders →

FAQ

How long has GMT CAPITAL CORP held CLOV?

GMT CAPITAL CORP has disclosed CLOV holdings in 9 of the last 12 reported quarters, going back to Q3 2023.

What is GMT CAPITAL CORP's current position in CLOV?

As of Q2 2026, GMT CAPITAL CORP holds 1.31M shares of CLOV (CLOVER HEALTH INVESTMENTS CO), valued at $6.84M, representing 0.36% of its reported portfolio and ranking #25.

Has GMT CAPITAL CORP been buying or selling CLOV?

In the latest 13F filing (Q2 2026), GMT CAPITAL CORP held unchanged its position in CLOV. The position peaked in Q2 2026 at 1.31M shares.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.